Flexan Acquires IntroMed
Lincolnshire, IL (April 16, 2018) – Flexan, LLC, a leading global medical device manufacturer of custom, high-precision silicone, rubber, and thermoplastic components, announced today the acquisition of IntroMed, LLC, a contract manufacturer of patent protected sheath introducers based in Salt Lake City, UT.
“We are excited to add IntroMed’s capabilities and technology to our array of contract manufacturing services,” said Jim Fitzgerald, President & CEO of Flexan, LLC. “Similar to the acquisition of MEDRON in December 2016, IntroMed has a reputation for providing innovative, high quality products and components to medical device OEMs.”
“We are thrilled to once again partner with Flexan,” said Eric King, Managing Partner of IntroMed. “The combination with MEDRON and the rest of the Flexan organization will bring significant value to our existing and new customers,” noted Mr. King.
In late 2016, Flexan acquired Salt Lake City-based MEDRON, LLC, which offers a range of outsource manufacturing services including high volume device production and packaging, design for manufacturability engineering support, rapid prototyping, and regulatory submission assistance.
“The addition of IntroMed enhances our contract manufacturing service offering as part of our continued focus on investing in and expanding the services we offer our global customer base,” said Ron Labrum, Linden Operating Partner. Mr. Labrum serves as Chairman of Flexan, LLC.
Flexan, LLC is a portfolio company of Linden Capital Partners.
Founded in 1946, Flexan, LLC is a global manufacturer of custom, high-precision silicone, rubber, and thermoplastic components for a broad array of product and industry applications, primarily used in medical devices but also including hearing technology, miniature pneumatics, industrial controls, and aerospace and defense, among others. Flexan, LLC markets its products under the FMI, Flexan, and MEDRON brands. The FMI and MEDRON brands deliver custom contract manufacturing services including molding, extrusion, and assembly for all classes of medical devices. The Flexan brand is synonymous with custom molding and expertise with molding difficult geometries as well as with bonding rubber to metal and other substrates, delivering high-precision, niche parts to a range of industries. Flexan (Suzhou) Precision Rubber Products, Ltd. is a wholly foreign owned entity in China. Suzhou manufactures products for both FMI and Flexan. Flexan, LLC sells its products worldwide and is headquartered in Lincolnshire, IL.
IntroMed was founded in 2005 by Ron Wortley, along with Dave Wortley and Eric King. IntroMed produces patent protected sheath introducers for use in catheter placements which benefit from the unique design of a movable valve. IntroMed has earned the trust of leading medical device manufacturers for their commitment to innovation in support of the advancement of patient care which is reliant on high quality vascular access catheters. IntroMed is headquartered in Salt Lake City, UT.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.
For more information, please contact Mike Huiras at Mike.Hurias@flexan.com or (773) 930-4969.